- Home
- QSI vs TNYA Comparison
QSI vs TNYA Comparison
Compare QSI & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- TNYA
- Stock Information
- Founded
- QSI 2013
- TNYA 2016
- Country
- QSI United States
- TNYA United States
- Employees
- QSI N/A
- TNYA N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- QSI Health Care
- TNYA Health Care
- Exchange
- QSI Nasdaq
- TNYA Nasdaq
- Market Cap
- QSI 208.6M
- TNYA 189.1M
- IPO Year
- QSI N/A
- TNYA 2021
- Fundamental
- Price
- QSI $1.09
- TNYA $1.30
- Analyst Decision
- QSI Strong Buy
- TNYA Strong Buy
- Analyst Count
- QSI 3
- TNYA 5
- Target Price
- QSI $2.38
- TNYA $8.60
- AVG Volume (30 Days)
- QSI 6.1M
- TNYA 4.7M
- Earning Date
- QSI 08-05-2025
- TNYA 11-05-2025
- Dividend Yield
- QSI N/A
- TNYA N/A
- EPS Growth
- QSI N/A
- TNYA N/A
- EPS
- QSI N/A
- TNYA N/A
- Revenue
- QSI $3,412,000.00
- TNYA N/A
- Revenue This Year
- QSI $45.62
- TNYA N/A
- Revenue Next Year
- QSI $218.03
- TNYA N/A
- P/E Ratio
- QSI N/A
- TNYA N/A
- Revenue Growth
- QSI 100.47
- TNYA N/A
- 52 Week Low
- QSI $0.61
- TNYA $0.36
- 52 Week High
- QSI $5.77
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- QSI 36.82
- TNYA 65.25
- Support Level
- QSI $0.95
- TNYA $1.05
- Resistance Level
- QSI $1.14
- TNYA $1.43
- Average True Range (ATR)
- QSI 0.07
- TNYA 0.10
- MACD
- QSI 0.02
- TNYA 0.01
- Stochastic Oscillator
- QSI 53.70
- TNYA 65.79
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.